Literature DB >> 36151499

Dissecting Lipopolysaccharide Composition and Structure by GC-MS and MALDI Spectrometry.

Pilar Garcia-Vello1, Immacolata Speciale1,2, Flaviana Di Lorenzo1, Antonio Molinaro1, Cristina De Castro3.   

Abstract

Lipopolysaccharides (LPSs) are the main components of the external leaflet of the outer membrane of Gram-negative bacteria. They exert multiple functions, starting from conferring stability to the bacterial membrane to mediating the interaction of the microbe with the external environment. The composition and the structure of LPSs present tremendous diversity even within bacteria of the same species, and for this reason, the determination of the structure of these molecules is crucial because it can provide information on the motifs key for the virulence of a pathogen or that are associated to a bacterium of the commensal or beneficial microbiota. In addition, structural data disclose the effects triggered from a mutation or from the use of an antibiotic, or they can be used as tools to check the quality of adjuvants and/or medications, as vaccines, that make use of LPS.The structural study of LPSs is complex, and it can be achieved with the right combination of different techniques. In this frame, this chapter focuses on the two MS-based approaches, the gas chromatography-mass spectrometry (GC-MS) and the matrix-assisted laser desorption/ionization (MALDI).
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carbohydrates; Gas chromatography-mass spectrometry (GC-MS); Glycoconjugates; Lipids; Lipopolysaccharide (LPS); Matrix-assisted laser desorption/ionization (MALDI)

Mesh:

Substances:

Year:  2022        PMID: 36151499     DOI: 10.1007/978-1-0716-2581-1_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  31 in total

1.  Bacterial modification of LPS and resistance to antimicrobial peptides.

Authors:  J S Gunn
Journal:  J Endotoxin Res       Date:  2001

Review 2.  The lipopolysaccharide of Shigella bacteria as a virulence factor.

Authors:  A A Lindberg; A Kärnell; A Weintraub
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

Review 3.  Advances in understanding bacterial outer-membrane biogenesis.

Authors:  Natividad Ruiz; Daniel Kahne; Thomas J Silhavy
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

Review 4.  Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions.

Authors:  Flaviana Di Lorenzo; Cristina De Castro; Alba Silipo; Antonio Molinaro
Journal:  FEMS Microbiol Rev       Date:  2019-05-01       Impact factor: 16.408

5.  Pseudomonas fluorescens adhesion and transport through porous media are affected by lipopolysaccharide composition.

Authors:  V Williams; M Fletcher
Journal:  Appl Environ Microbiol       Date:  1996-01       Impact factor: 4.792

Review 6.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

Review 7.  Structure and function: Lipid A modifications in commensals and pathogens.

Authors:  Alex Steimle; Ingo B Autenrieth; Julia-Stefanie Frick
Journal:  Int J Med Microbiol       Date:  2016-03-05       Impact factor: 3.473

Review 8.  Pushing the envelope: LPS modifications and their consequences.

Authors:  Brent W Simpson; M Stephen Trent
Journal:  Nat Rev Microbiol       Date:  2019-07       Impact factor: 60.633

9.  Structure of O-Antigen and Hybrid Biosynthetic Locus in Burkholderia cenocepacia Clonal Variants Recovered from a Cystic Fibrosis Patient.

Authors:  A A Hassan; Rita F Maldonado; Sandra C Dos Santos; Flaviana Di Lorenzo; Alba Silipo; Carla P Coutinho; Vaughn S Cooper; Antonio Molinaro; Miguel A Valvano; Isabel Sá-Correia
Journal:  Front Microbiol       Date:  2017-06-08       Impact factor: 5.640

10.  Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Authors:  Cristina Cigana; Laura Curcurù; Maria Rosaria Leone; Teresa Ieranò; Nicola Ivan Lorè; Irene Bianconi; Alba Silipo; Flora Cozzolino; Rosa Lanzetta; Antonio Molinaro; Maria Lina Bernardini; Alessandra Bragonzi
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.